Advocating for Access to Oral Myeloma Treatments

There have been several recent FDA approvals in myeloma — all of which are oral medications. But what if your doctor suggests a medication for you and your insurance won’t cover it?  Meghan Buzby, Director of US Advocacy for the IMF, tells Patient Power in this video interview what Myeloma patients can do to help all patients access oral anticancer treatments. She explains that insurance reimbursement issues can create high out-of-pocket costs for patients. Meghan notes, “it is so important for patients to reach out to their legislators because their personal stories are what the legislator is going to connect with.” 

Mbuzby_PatientPower

421 total views, 3 views today